← All claims

Metabolic & Cardiometabolic

cellular chickpea flour decreases postprandial glucose

In plain terms: Does coarse chickpea flour lower blood sugar after a meal?

Strong support Metabolic & Cardiometabolic 🔬 Includes disconfirming

Part of: • Chickpea Flour

RefutedContestedStrong support
consensus score 0.62

Yes, when coarsely milled so starch stays locked in cells; grinding it fine erases the benefit.

🧭 Read this score with how it was built in mindStudies we had treated as independent turned out to share a research group

No new research arrived. Two of the trials supporting this claim were recorded as separate studies but are one: a King's College London crossover trial (registered NCT03994276) in which the same twenty volunteers ate bread made with 0%, 30% or 60% cellular chickpea flour. A 2021 paper reported their blood-glucose results and a 2023 paper reported their gut-hormone and insulin results. Both point the same way and both still count — but as one study, not two. The finding is unchanged; we were counting a single trial twice.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

7 support 0 contradict 1 tested null 2 mixed · 10 sources, 7 independent groups · 2 superseded — pooled inside a review, counted once

What the evidence shows

Coarse, cellular chickpea flour attenuates postprandial glucose; fine milling erases the benefit (cell-wall encapsulation of starch is the active mechanism).

The evidence (14)

SourceGradeStanceQualityFinding
Alshaalan RA, Charalambides MN, Edwards CH, Ellis PR, Alrabeah SH, Frost GS
2024 · Food Research International
RCT supports moderate Hummus from intact chickpea cells gave lower insulin and GIP and slower in-vitro starch digestion than ruptured-cell hummus; cell-wall integrity slows digestion.
Cai M, Tejpal S, Tashkova M, Ryden P, Perez-Moral N, Saha S, Garcia-Perez I, Serrano Contreras JI, Wist J, Holmes E, Bernal A, Dou B, Becker GF, Frost G, Edwards C
2025 · Nature Metabolism
RCT supports moderate Cellular chickpea bread altered upper-GI metabolite profile, lowering glycaemic and raising satiety responses vs control; mechanism for cell-encapsulated starch.
Schlicker L, Boers HM, Dudek CA, Zhao G, Barua A, Trezzi JP, Meyer-Hermann M, Jacobs DM, Hiller K
2019 · Metabolites
RCT mixed moderate Human crossover (n=12) testing flatbread with guar gum +/- 15% chickpea flour vs control on postprandial glucose-derived metabolite flux; glucose appearance rate was attenuated by the fiber mix (mainly guar gum), but the study does not isol
Kanata MC, Yanni AE, Koliaki C, Anastasiou IA, Tentolouris N, Karathanos VT
2025 · (RCT)
RCT supports moderate Coarse (1.4-1.8mm) chickpea blunted glucose/insulin; fine milling lost it
Winham DM, Camacho-Arriola M, Glick AA, Hall CA, Shelley MC
2025 · Foods
RCT mixed moderate Whole pulses lowered glycaemia but equivalent pulse FLOURS raised postprandial glucose in T2D/MetS—cell-wall disruption by milling abolishes benefit, supporting cellularity.
Thomas DJ, Shafiee M, Nosworthy MG, Lane G, Ramdath DD, Vatanparast H
2023 · Nutrients
observational supports low Scoping review of pulses in T2D management found consistent postprandial glucose and HbA1c benefits across legume interventions.
Delamare GYF, Butterworth PJ, Ellis PR, Hill S, Warren FJ, Edwards CH
2020 · Food Chem X
in-vitro supports moderate PulseON cellular legume ingredient (RS1) replacing wheat flour in biscuits dose-dependently reduced in-vitro starch digestibility, predicting lower glycaemic index.
Hafiz MS, Campbell MD, O'Mahoney LL, Holmes M, Orfila C, Boesch C
2022 · Eur J Nutr
meta-analysis supports moderate Meta-analysis: pulse consumption improved glycemic control indices in adults with and without diabetes, consistent with slow-digesting legume starch matrix.
Bajka BH, Pinto AM, Ahn-Jarvis J, Ryden P, Perez-Moral N, van der Schoot A, Stocchi C, Bland C, Berry SE, Ellis PR, Edwards CH
2021 · Food Hydrocolloids
RCT supports high Replacing wheat flour with cellular chickpea powder in bread rolls (intact cell-encapsulated starch) cut postprandial glucose iAUC ~40% in healthy adults.
↩ SUPERSEDED — pooled in the review above, counted once
Bajka BH, Pinto AM, Perez-Moral N, Saha S, Ryden P, Ahn-Jarvis J, van der Schoot A, Bland C, Berry SE, Ellis PR, Edwards CH
2023 · Am J Clin Nutr
RCT supports moderate Cellular chickpea bread improved glycemia & raised satiety hormones
↩ SUPERSEDED — pooled in the review above, counted once
Frost G et al
2024 · Research Square
RCT supports moderate Human randomised crossover (n=10) comparing 'Broken' vs 'Intact' cell-structure iso-nutrient chickpea meals. Broken cell structure gave high starch digestibility and sharp postprandial glycemia/GIP/GLP-1 rise; Intact cells produced prolonge
Mah E, Uffelman CN, Blonquist TM, Wang DD, Rehm CD, Goltz SR, Chu Y
2025 · (SR/MA)
meta-analysis supports low Chickpea significantly attenuates postprandial glucose
Hafiz MS, Campbell MD, Orsi NM, Mappa G, Orfila C, Boesch C
2022 · Food Funct
RCT supports moderate Minimally processed chickpea preserving cell structure produced lower postprandial glycaemia and greater satiety than disrupted/processed forms in healthy adults.
Fahmi R, Blewett H, Stebbing JA, Olson N, Ryland D, Aliani M
2022 · Foods
RCT tested-null moderate Split-pea-enriched white pan bread reduced postprandial glucose response and improved satiety vs control bread in healthy volunteers (pulse fibre/structure effect).

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.